Neuronetics (STIM) delivered earnings and revenue surprises of -18.18% and -2.21%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

CFO and COO Mark Hirschhorn reported, "in the third quarter, we delivered results ahead of expectations for both revenue and adjusted EBITDA, reflecting stronger subscription retention, increased ...

Get the latest Compass Pathways Q3 2025 earnings insights: accelerated COMP360 launch plans, regulatory updates, and financial outlook.

FY25 revenue consensus $247.79M. Narrows FY25 adjusted EBITDA guidance to ($45M)-($42M) from ($50M)-($45M). Reaffirms AMG visits view 1.3M-1.35M.